|
Volumn 134, Issue 2, 2014, Pages 483-485
|
Eczema and race as combined determinants for differential response to step-up asthma therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUTICASONE;
IMMUNOGLOBULIN E;
MONTELUKAST;
SALMETEROL;
STEROID;
ACETIC ACID DERIVATIVE;
ANDROSTANE DERIVATIVE;
ANTIASTHMATIC AGENT;
DRUG COMBINATION;
FLUTICASONE, SALMETEROL DRUG COMBINATION;
QUINOLINE DERIVATIVE;
SALBUTAMOL;
ADD ON THERAPY;
ADOLESCENT;
ASTHMA;
BODY MASS;
CHILD;
CONTROLLED STUDY;
ECZEMA;
EOSINOPHIL;
FEMALE;
FORCED EXPIRATORY VOLUME;
GENETIC VARIABILITY;
HUMAN;
IMMUNOGLOBULIN BLOOD LEVEL;
LETTER;
LOW DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RACE DIFFERENCE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SKIN TEST;
STEROID THERAPY;
TREATMENT DURATION;
TREATMENT RESPONSE;
AFRICAN AMERICAN;
ANALOGS AND DERIVATIVES;
CAUCASIAN;
COMPLICATION;
CROSSOVER PROCEDURE;
DRUG COMBINATION;
DRUG MONITORING;
ETHNOLOGY;
HISPANIC;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ACETATES;
ADOLESCENT;
AFRICAN AMERICANS;
ALBUTEROL;
ANDROSTADIENES;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
CHILD;
CROSS-OVER STUDIES;
DRUG COMBINATIONS;
DRUG MONITORING;
ECZEMA;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
FEMALE;
HISPANIC AMERICANS;
HUMANS;
MALE;
QUINOLINES;
|
EID: 84905572123
PISSN: 00916749
EISSN: 10976825
Source Type: Journal
DOI: 10.1016/j.jaci.2014.03.039 Document Type: Article |
Times cited : (26)
|
References (8)
|